rs759499740
Variant summary
Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBS1_SupportingBS2
The NM_002047.4(GARS1):c.112G>A(p.Ala38Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000058 in 1,568,504 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position (i.e. A38A) has been classified as Likely benign.
Frequency
Consequence
NM_002047.4 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -9 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| GARS1 | ENST00000389266.8 | c.112G>A | p.Ala38Thr | missense_variant | Exon 1 of 17 | 1 | NM_002047.4 | ENSP00000373918.3 | ||
| GARS1 | ENST00000675651.1 | c.112G>A | p.Ala38Thr | missense_variant | Exon 1 of 17 | ENSP00000502513.1 | ||||
| GARS1 | ENST00000675810.1 | c.112G>A | p.Ala38Thr | missense_variant | Exon 1 of 16 | ENSP00000502743.1 | ||||
| GARS1 | ENST00000444666.6 | n.112G>A | non_coding_transcript_exon_variant | Exon 1 of 18 | 3 | ENSP00000415447.2 | ||||
| GARS1 | ENST00000674616.1 | n.112G>A | non_coding_transcript_exon_variant | Exon 1 of 18 | ENSP00000502408.1 | |||||
| GARS1 | ENST00000674643.1 | n.112G>A | non_coding_transcript_exon_variant | Exon 1 of 17 | ENSP00000501636.1 | |||||
| GARS1 | ENST00000674737.1 | n.112G>A | non_coding_transcript_exon_variant | Exon 1 of 18 | ENSP00000502464.1 | |||||
| GARS1 | ENST00000674807.1 | n.112G>A | non_coding_transcript_exon_variant | Exon 1 of 16 | ENSP00000502814.1 | |||||
| GARS1 | ENST00000675529.1 | n.112G>A | non_coding_transcript_exon_variant | Exon 1 of 18 | ENSP00000501655.1 | |||||
| GARS1 | ENST00000675859.1 | n.112G>A | non_coding_transcript_exon_variant | Exon 1 of 15 | ENSP00000502033.1 | |||||
| GARS1 | ENST00000676088.1 | n.112G>A | non_coding_transcript_exon_variant | Exon 1 of 19 | ENSP00000501884.1 | |||||
| GARS1 | ENST00000676140.1 | n.112G>A | non_coding_transcript_exon_variant | Exon 1 of 17 | ENSP00000502571.1 | |||||
| GARS1 | ENST00000676164.1 | n.112G>A | non_coding_transcript_exon_variant | Exon 1 of 17 | ENSP00000501986.1 | |||||
| GARS1 | ENST00000676210.1 | n.112G>A | non_coding_transcript_exon_variant | Exon 1 of 18 | ENSP00000502373.1 | |||||
| GARS1 | ENST00000676259.1 | n.112G>A | non_coding_transcript_exon_variant | Exon 1 of 17 | ENSP00000501980.1 | |||||
| GARS1 | ENST00000676403.1 | n.112G>A | non_coding_transcript_exon_variant | Exon 1 of 16 | ENSP00000502681.1 | |||||
| GARS1 | ENST00000675693.1 | c.19-75G>A | intron_variant | Intron 1 of 17 | ENSP00000502174.1 | |||||
| GARS1 | ENST00000675051.1 | c.22-3763G>A | intron_variant | Intron 1 of 16 | ENSP00000502296.1 | |||||
| GARS1 | ENST00000674815.1 | c.-148+81G>A | intron_variant | Intron 1 of 16 | ENSP00000502799.1 | |||||
| GARS1 | ENST00000674851.1 | c.-183-75G>A | intron_variant | Intron 1 of 17 | ENSP00000502451.1 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152186Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000172 AC: 3AN: 174926 AF XY: 0.0000104 show subpopulations
GnomAD4 exome AF: 0.0000621 AC: 88AN: 1416318Hom.: 0 Cov.: 31 AF XY: 0.0000555 AC XY: 39AN XY: 702212 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152186Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74344 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
not provided Uncertain:2
The GARS1 c.112G>A; p.Ala38Thr variant (rs759499740), to our knowledge, is not reported in the medical literature but is reported in ClinVar (Variation ID: 573677). This variant is only observed on four alleles in the Genome Aggregation Database, indicating it is not a common polymorphism. The alanine at codon 38 is weakly conserved, but computational analyses are uncertain whether this variant is neutral or deleterious (REVEL: 0.177). However, given the lack of clinical and functional data, the significance of this variant is uncertain at this time. -
In silico analysis suggests that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
Charcot-Marie-Tooth disease type 2 Uncertain:1
This sequence change replaces alanine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 38 of the GARS protein (p.Ala38Thr). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This variant has not been reported in the literature in individuals affected with GARS-related conditions. ClinVar contains an entry for this variant (Variation ID: 573677). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt GARS protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Charcot-Marie-Tooth disease type 2D Uncertain:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at